Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00010309 | Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | — | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00796991 | Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine | completed | Phase 1 | 72 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00022568 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma |
| unknown |
| Phase 1 |
| — |
| Herbert Irving Comprehensive Cancer CenterOTHER |
| 1 |
| Dec 18, 2013 |
| clinicaltrials |
| NCT00037037 | Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma | unknown | Phase 1 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00391300 | Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | unknown | Phase 1 | 100 | Eastern Virginia Medical SchoolOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | completed | Phase 1 / Phase 2 | 50 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00358319 | Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma | terminated | Phase 1 / Phase 2 | 42 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00007969 | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | QLT Inc.INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003747 | Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma | unknown | Phase 1 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00016055 | Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | 18 | St. Luke's Medical CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01944709 | Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma | terminated | Phase 1 / Phase 2 | 2 | Prof. Dr. Silke GillessenOTHER | 1 | Sep 18, 2013 | clinicaltrials |
| NCT00002781 | Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma | unknown | Phase 1 | 15 | Beth Israel Deaconess Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00006035 | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00017355 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00126685 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 30 | Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum ErlangenOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00147550 | MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. | terminated | Phase 1 / Phase 2 | 79 | PfizerINDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00002952 | Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01743157 | Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma(BBI) | completed | Phase 1 / Phase 2 | 24 | California Pacific Medical Center Research InstituteOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT01082198 | Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes | unknown | Phase 1 / Phase 2 | 22 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT00815607 | Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT01011530 | Dose Escalation Study of MLN4924 in Adults With Melanoma | completed | Phase 1 | 37 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00948467 | Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies | completed | Phase 1 | 51 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00003792 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00039572 | Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain | completed | Phase 1 / Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019214 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00058279 | Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005633 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005815 | Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00313235 | Combined Modality Treatment for Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 41 | Baylor Research InstituteOTHER | 1 | Jun 13, 2013 | clinicaltrials |
| NCT01245556 | Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma | completed | Phase 1 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00004016 | Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | completed | Phase 1 | — | University of RochesterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00005943 | Gene Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | University of Colorado, DenverOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00112476 | Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00217542 | Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT01032122 | Rituximab in Metastatic Melanoma | terminated | Phase 1 | 9 | Medical University of ViennaOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT00112216 | Immunotherapy of Melanoma Patients | completed | Phase 1 | 9 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00112229 | Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients | completed | Phase 1 | 29 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Apr 22, 2013 | clinicaltrials |
| NCT00004184 | Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 50 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01340729 | Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00091143 | Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma | completed | Phase 1 | 20 | Providence Cancer Center, Earle A. Chiles Research InstituteOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00003229 | Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | completed | Phase 1 / Phase 2 | — | Duke UniversityOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004244 | Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00104845 | Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 12, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Jan 6, 2014source: clinicaltrials